Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Keystone

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Rheumatology|February 1, 1992
Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndromeM M Khraishi, V Jay, E C Keystone
Clinical and Experimental Rheumatology|February 19, 2004
Role of infliximab in the treatment of early rheumatoid arthritisE C Keystone, B Haraoui, V P Bykerk
Arthritis and Rheumatism|July 1, 1993
Restricted cytokine expression in rheumatoid arthritisE Chen, E C Keystone, E N Fish
Cellular Immunology|September 15, 1980
Antigen-specific suppressor cell activity in man: I. Temporal, antigenic, and proliferative requirementsE C Keystone, D D Gladman, D Cane
Clinical and Experimental Rheumatology|February 19, 2004
Role of adalimumab in the treatment of early rheumatoid arthritisE C Keystone, B Haraoui, V P Bykerk
Arthritis and Rheumatism|February 1, 1982
Antigen-specific suppressor cell activity in procainamide therapyC J Shamess, S Klein, E C Keystone
Annals of the Rheumatic Diseases|February 1, 1980
Polyarthritis due to Mycobacterium kansasii in a patient with rheumatoid arthritisP DeMerieux, E C Keystone, M Hutcheon, et al.
The Journal of Investigative Dermatology|April 1, 1983
Aberrations in T-cell subpopulations in patients with psoriasis and psoriatic arthritisD D Gladman, E C Keystone, R K Schacter
Annals of the Rheumatic Diseases|August 30, 2008
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse eventsJ P Leombruno, T R Einarson, E C Keystone
The American Journal of Medicine|February 1, 1979
Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic featuresD D Gladman, M B Urowitz, E C Keystone
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Rheumatology|February 1, 1992
Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndromeM M Khraishi, V Jay, E C Keystone
Clinical and Experimental Rheumatology|February 19, 2004
Role of infliximab in the treatment of early rheumatoid arthritisE C Keystone, B Haraoui, V P Bykerk
Arthritis and Rheumatism|July 1, 1993
Restricted cytokine expression in rheumatoid arthritisE Chen, E C Keystone, E N Fish
Cellular Immunology|September 15, 1980
Antigen-specific suppressor cell activity in man: I. Temporal, antigenic, and proliferative requirementsE C Keystone, D D Gladman, D Cane
Clinical and Experimental Rheumatology|February 19, 2004
Role of adalimumab in the treatment of early rheumatoid arthritisE C Keystone, B Haraoui, V P Bykerk
Arthritis and Rheumatism|February 1, 1982
Antigen-specific suppressor cell activity in procainamide therapyC J Shamess, S Klein, E C Keystone
Annals of the Rheumatic Diseases|February 1, 1980
Polyarthritis due to Mycobacterium kansasii in a patient with rheumatoid arthritisP DeMerieux, E C Keystone, M Hutcheon, et al.
The Journal of Investigative Dermatology|April 1, 1983
Aberrations in T-cell subpopulations in patients with psoriasis and psoriatic arthritisD D Gladman, E C Keystone, R K Schacter
Annals of the Rheumatic Diseases|August 30, 2008
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse eventsJ P Leombruno, T R Einarson, E C Keystone
The American Journal of Medicine|February 1, 1979
Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic featuresD D Gladman, M B Urowitz, E C Keystone
Pageof 13